All Stories

  1. FAM168B identified as a novel candidate target for chimeric antigen receptor T cell-based cancer therapy
  2. Cell cycle-regulated expression of Fam72a from the |Srgap2–Fam72a| master gene leads to Mis18a downregulation
  3. Microplastic Pollution in Aquaculture: Challenges and Mitigation
  4. Deciphering the molecular landscape of the FAM72 gene family: Implications for stem cell biology and cancer
  5. Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
  6. Antioxidant Activities of Photoinduced Phycogenic Silver Nanoparticles and Their Potential Applications
  7. Antibacterial, Antifungal, and Antioxidant Activities of Silver Nanoparticles Biosynthesized from Bauhinia tomentosa Linn
  8. Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing
  9. Phytochemical Profiling in Conjunction with In Vitro and In Silico Studies to Identify Human α-Amylase Inhibitors in Leucaena leucocephala (Lam.) De Wit for the Treatment of Diabetes Mellitus
  10. FAM72, Glioblastoma Multiforme (GBM) and Beyond
  11. Identification of a Novel Thermostable Alkaline Protease from Bacillus megaterium-TK1 for the Detergent and Leather Industry
  12. Cover Picture: Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase (Mol. Inf. 5/2020)
  13. Improvement of Saccharification and Delignification Efficiency of Trichoderma reesei Rut-C30 by Genetic Bioengineering
  14. Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase
  15. Gastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia
  16. Accurate high throughput alignment via line sweep-based seed processing
  17. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis
  18. A Novel Divergent Gene Transcription Paradigm—the Decisive, Brain-Specific, Neural |-Srgap2–Fam72a-| Master Gene Paradigm
  19. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature
  20. Establishing a Human Adrenocortical Carcinoma (ACC)-Specific Gene Mutation Signature
  21. Brain plasticity, cognitive functions and neural stem cells: a pivotal role for the brain-specific neural master gene |-SRGAP2–FAM72-|
  22. Functional repertoire of interleukin-6 in the central nervous system – a review
  23. A novel specialized single-linkage clustering algorithm for taxonomically ordered data
  24. Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation
  25. Cognitive Functions: Human vs. Animal – 4:1 Advantage |-FAM72–SRGAP2-|
  26. Livebearing or egg-laying mammals: 27 decisive nucleotides of FAM168
  27. Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
  28. Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer
  29. All-or-(N)One – an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci
  30. Characterization of a solvent, surfactant and temperature-tolerant laccase from Pleurotus sp. MAK-II and its dye decolorizing property
  31. Characterization of a Solvent-Tolerant Manganese Peroxidase (MnP) fromGanoderma Lucidumand Its Application in Fruit Juice Clarification
  32. 3D Structure, Dimerization Modeling, and Lead Discovery by Ligand-protein Interaction Analysis of p60 Transcription Regulator Protein (p60TRP)
  33. Characterization of a novel endoglucanase fromGanoderma lucidum
  34. Ageing, dementia and society – an epistemological perspective
  35. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
  36. Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
  37. Mechanism Study of Traditional Medicine Using Proteomics Alone or Integrated with Other Systems Biology Technologies
  38. Characterization of Lignocellulolytic Enzymes from White-Rot Fungi
  39. Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17)
  40. Oxygen distribution in proteins defines functional significance of the genome and proteome of the malaria parasite Plasmodium falciparum 3D7
  41. Thymine distribution in genes provides novel insight into the functional significance of the proteome of the malaria parasite Plasmodium falciparum 3D7
  42. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology
  43. Brain site-specific proteome changes in aging-related dementia
  44. The protein p17 signaling pathways in cancer
  45. Establishing an in vivo p48ZnF bioluminescence mouse brain imaging model
  46. G Proteins, p60TRP, and Neurodegenerative Diseases
  47. Brain-Site-Specific Proteome Changes Induced by Neuronal P60TRP Expression
  48. Characterization of optimized production, purification and application of laccase from Ganoderma lucidum
  49. Secretome analysis of Ganoderma lucidum cultivated in sugarcane bagasse
  50. Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain
  51. MAGNITUDE OF THYMINE IN DIFFERENT FRAMES OF MESSENGER RNAs
  52. Characterizing the neurite outgrowth inhibitory effect of Mani
  53. Tianma Modulates Blood Vessel Tonicity
  54. Tianma modulates proteins with various neuro-regenerative modalities in differentiated human neuronal SH-SY5Y cells
  55. New insights into the brain protein metabolism of Gastrodia elata-treated rats by quantitative proteomics
  56. Neuronal p60TRP expression modulates cardiac capacity
  57. Phenotyping of Tianma-Stimulated Differentiated Rat Neuronal B104 Cells by Quantitative Proteomics
  58. Quantitative Neuroproteomics of an In Vivo Rodent Model of Focal Cerebral Ischemia/Reperfusion Injury Reveals a Temporal Regulation of Novel Pathophysiological Molecular Markers
  59. P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis
  60. The novel protein MANI modulates neurogenesis and neurite-cone growth
  61. Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice
  62. Characterizing the novel protein p33MONOX
  63. Neurotrophin-4 (Ntf4) Mediates Neurogenesis in Mouse Embryonic Neural Stem Cells Through the Inhibition of the Signal Transducer and Activator of Transcription-3 (Stat3) and the Modulation of the Activity of Protein Kinase B
  64. Cardiovascular Dementia - A Different Perspective
  65. Phenotyping of an in Vitro Model of Ischemic Penumbra by iTRAQ-Based Shotgun Quantitative Proteomics
  66. Ligand-Dependent Activation of the Chimeric Tumor Necrosis Factor Receptor-Amyloid Precursor Protein (APP) Reveals Increased APP Processing and Suppressed Neuronal Differentiation
  67. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17
  68. Brain-Derived Neurotrophic Factor (BDNF) has Proliferative Effects on Neural Stem Cells through the Truncated TRK-B Receptor, MAP Kinase, AKT, and STAT-3 Signaling Pathways
  69. Interleukin-6 and Neural Stem Cells: More Than Gliogenesis
  70. Neurotrophins - More than Neurotrophic
  71. Death effector domain DEDa, a self-cleaved product of caspase-8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase-8 expression via a p53-dependent mechanism
  72. ABC transporters, neural stem cells and neurogenesis – a different perspective
  73. Brain site-specific gene expression analysis in Alzheimer's disease patients
  74. The Bad Guy Cooperates with Good Cop p53: Bad Is Transcriptionally Up-Regulated by p53 and Forms a Bad/p53 Complex at the Mitochondria To Induce Apoptosis
  75. Livin promotes Smac/DIABLO degradation by ubiquitin–proteasome pathway
  76. Alzheimers Disease - An Interactive Perspective
  77. Cytokines and Neurotrophins Interact in Normal and Diseased States
  78. Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease
  79. Nerve growth factor(NGF) induces mRNA expression of the new transcription factor protein p48ZnF
  80. Identification of rTid-1, the rat homologue of the drosophila tumor suppressor l(2)tid gene
  81. The Splicing Regulatory Protein p18SRP Is Down-Regulated in Alzheimer's Disease Brain
  82. The possible mechanisms of Aβ(1-40)- or Aβ(1-42)-induced cell death and their rescue factors
  83. Characterizing the new transcription regulator protein p60TRP
  84. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells
  85. Comparative gene identification-94—a pivotal regulator of apoptosis
  86. Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells
  87. Characterizing the signaling pathway of rat p18 amyloid beta (A??) responsive protein (p18A??rP).
  88. The 3′ untranslated region of the new rat synaptic vesicle protein 2B mRNA transcript inhibits translational efficiency
  89. Characterizing CGI-94 (comparative gene identification-94) which is down-regulated in the hippocampus of early stage Alzheimer's disease brain
  90. Identification of a New Synaptic Vesicle Protein 2B mRNA Transcript Which Is Up-Regulated in Neurons by Amyloid β Peptide Fragment (1–42)
  91. Signals regulating neurotrophin expression in glial cells
  92. Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2
  93. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression
  94. Induction of rat l-phosphoserine phosphatase by amyloid-β (1–42) is inhibited by interleukin-11
  95. Region-Specific Neurotrophin Imbalances in Alzheimer Disease
  96. Increased CSF levels of nerve growth factor in patients with Alzheimer's disease
  97. GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats
  98. Alterations in neurotrophins and neurotrophin receptors in Alzheimer’s disease
  99. Modulation of mRNA expression of the neurotrophins of the nerve-growth-factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment. II. Effects on p75 and trk receptor expression
  100. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression
  101. NF-?B modulates lipopolysaccharide-induced microglial nerve growth factor expression
  102. Modulation of mRNA expression of the neurotrophins of the nerve growth factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment
  103. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease
  104. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients
  105. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors